Needham & Company Maintains a 'Buy' on Vertex (VRTX); Adjusting Q2 Lower, But Positive on Cash Flow
Go back to Needham & Company Maintains a 'Buy' on Vertex (VRTX); Adjusting Q2 Lower, But Positive on Cash Flow| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 552.06 +23.87 (4.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $528.19 | 52 Week High | $134.71 | |||
| Open | $537.47 | 52 Week Low | $73.31 | |||
| Day High | $553.69 | P/E | N/A | |||
| Day Low | $532.55 | EPS | $-1.98 | |||
| Volume | 1,437,678 | |||||
